These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18833280)

  • 1. Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease.
    Tang C; Louis JM; Aniana A; Suh JY; Clore GM
    Nature; 2008 Oct; 455(7213):693-6. PubMed ID: 18833280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal interface conformations modulate dimer stability prior to amino terminal autoprocessing of HIV-1 protease.
    Agniswamy J; Sayer JM; Weber IT; Louis JM
    Biochemistry; 2012 Feb; 51(5):1041-50. PubMed ID: 22242794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoprocessing of HIV-1 protease is tightly coupled to protein folding.
    Louis JM; Clore GM; Gronenborn AM
    Nat Struct Biol; 1999 Sep; 6(9):868-75. PubMed ID: 10467100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flexible catalytic site conformations implicated in modulation of HIV-1 protease autoprocessing reactions.
    Huang L; Li Y; Chen C
    Retrovirology; 2011 Oct; 8():79. PubMed ID: 21985091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.
    Yu FH; Wang CT
    Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity.
    Counts CJ; Ho PS; Donlin MJ; Tavis JE; Chen C
    PLoS One; 2015; 10(4):e0123561. PubMed ID: 25893662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus (HIV) type 1 transframe protein can restore activity to a dimerization-deficient HIV protease variant.
    Dautin N; Karimova G; Ladant D
    J Virol; 2003 Aug; 77(15):8216-26. PubMed ID: 12857890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient HIV-1 Gag-protease interactions revealed by paramagnetic NMR suggest origins of compensatory drug resistance mutations.
    Deshmukh L; Louis JM; Ghirlando R; Clore GM
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12456-12461. PubMed ID: 27791180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of human immunodeficiency virus type 1 protease autoprocessing by charge properties of surface residue 69.
    Huang L; Sayer JM; Swinford M; Louis JM; Chen C
    J Virol; 2009 Aug; 83(15):7789-93. PubMed ID: 19457992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.
    Yu FH; Huang KJ; Wang CT
    J Virol; 2017 May; 91(10):. PubMed ID: 28250114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding HIV-1 protease autoprocessing for novel therapeutic development.
    Huang L; Chen C
    Future Med Chem; 2013 Jul; 5(11):1215-29. PubMed ID: 23859204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoprocessing of the human immunodeficiency virus type 1 protease precursor expressed in Escherichia coli from a synthetic gene.
    Valverde V; Lemay P; Masson JM; Gay B; Boulanger P
    J Gen Virol; 1992 Mar; 73 ( Pt 3)():639-51. PubMed ID: 1545221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA; Perez EE; Lamers SL; Farmerie WG; Dunn BM; Sleasman JW; Goodenow MM
    Virology; 1996 May; 219(2):407-16. PubMed ID: 8638406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of Clinical Inhibitors to a Model Precursor of a Rationally Selected Multidrug Resistant HIV-1 Protease Is Significantly Weaker Than That to the Released Mature Enzyme.
    Park JH; Sayer JM; Aniana A; Yu X; Weber IT; Harrison RW; Louis JM
    Biochemistry; 2016 Apr; 55(16):2390-400. PubMed ID: 27039930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding kinetics and substrate selectivity in HIV-1 protease-Gag interactions probed at atomic resolution by chemical exchange NMR.
    Deshmukh L; Tugarinov V; Louis JM; Clore GM
    Proc Natl Acad Sci U S A; 2017 Nov; 114(46):E9855-E9862. PubMed ID: 29087351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoprocessing: an essential step for the activation of HIV-1 protease.
    Wan M; Takagi M; Loh BN; Xu XZ; Imanaka T
    Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):569-73. PubMed ID: 8687402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure of the mature HIV-1 protease monomer: insight into the tertiary fold and stability of a precursor.
    Ishima R; Torchia DA; Lynch SM; Gronenborn AM; Louis JM
    J Biol Chem; 2003 Oct; 278(44):43311-9. PubMed ID: 12933791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folded monomer of HIV-1 protease.
    Ishima R; Ghirlando R; Tözsér J; Gronenborn AM; Torchia DA; Louis JM
    J Biol Chem; 2001 Dec; 276(52):49110-6. PubMed ID: 11598128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein.
    Louis JM; Nashed NT; Parris KD; Kimmel AR; Jerina DM
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7970-4. PubMed ID: 8058744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.